data_2m3i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m3i _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.442 -0.826 0 CA-C-O 121.553 0.692 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -131.94 125.02 19.99 Favored Pre-proline 0 N--CA 1.435 -1.206 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -25.25 -53.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 1 C-N-CA 126.601 4.867 . . . . 0.0 117.39 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 11' ' ' MET . 27.7 m -65.05 -42.64 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 m -76.81 -31.23 56.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -64.63 -26.03 68.22 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.037 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.71 -15.3 35.16 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.121 0.486 . . . . 0.0 110.595 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.6 mmt -74.32 -51.59 14.72 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -130.38 100.96 17.84 Favored Pre-proline 0 C--N 1.278 -2.535 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.985 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -3.16 12.9 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.197 1.931 . . . . 0.0 111.237 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -92.98 -10.1 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 122.697 1.237 . . . . 0.0 108.581 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.286 -2.166 0 CA-C-N 113.983 -1.462 . . . . 0.0 108.557 179.513 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.802 0.811 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t . . . . . 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 121.259 0.552 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -131.57 126.53 21.13 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -28.81 -54.1 0.15 Allowed 'Trans proline' 0 C--N 1.368 1.569 1 C-N-CA 126.133 4.555 . . . . 0.0 116.086 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.76 -36.0 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.81 -22.72 20.87 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -69.24 -29.2 67.07 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.271 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.99 -28.88 25.48 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.032 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.0 ttt -60.09 -54.13 49.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.137 0.97 . . . . 0.0 109.134 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -133.55 97.41 15.93 Favored Pre-proline 0 C--N 1.272 -2.796 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.882 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.06 3.44 6.15 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.762 2.308 . . . . 0.0 112.387 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.9 mm -97.78 -10.41 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.524 1.154 . . . . 0.0 108.041 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t . . . . . 0 C--N 1.29 -1.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.848 -177.703 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.233 0.54 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -125.82 110.03 25.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -40.85 -50.4 4.05 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 125.009 3.806 . . . . 0.0 115.449 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.5 t -66.59 -31.61 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.811 0.815 . . . . 0.0 110.353 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.1 t -87.77 -17.15 32.28 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.987 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 m -67.74 -16.98 64.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.694 0.759 . . . . 0.0 110.291 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.99 -22.52 20.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.27 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.4 mmm -77.36 -39.42 47.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -125.51 87.58 55.52 Favored Pre-proline 0 C--N 1.273 -2.717 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.83 4.33 3.21 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.4 -32.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.348 1.07 . . . . 0.0 108.189 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.279 -2.494 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.998 176.707 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -138.2 129.63 15.8 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -28.16 -48.33 0.11 Allowed 'Trans proline' 0 C--N 1.369 1.635 1 C-N-CA 126.553 4.835 . . . . 0.0 116.162 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.475 HG22 ' SG ' ' A' ' 8' ' ' CYS . 31.4 m -55.62 -32.24 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.475 ' SG ' HG22 ' A' ' 7' ' ' VAL . 4.6 m -107.72 -21.99 12.66 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.559 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -63.53 -39.27 93.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 110.426 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.6 -20.64 33.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.87 -47.75 76.72 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.982 0.896 . . . . 0.0 109.438 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.4 t -135.48 97.43 13.02 Favored Pre-proline 0 C--N 1.277 -2.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.543 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.85 -1.75 11.25 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.268 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.25 -28.66 6.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 123.032 1.396 . . . . 0.0 107.711 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 C--N 1.273 -2.738 0 CA-C-N 112.451 -2.159 . . . . 0.0 109.643 -177.152 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.226 -0.182 0 CA-C-O 121.484 0.659 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -101.98 120.47 53.78 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -37.43 -55.99 0.92 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.636 3.557 . . . . 0.0 115.983 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 11' ' ' MET . 33.2 m -67.54 -28.99 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.472 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.05 -24.25 47.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -18.22 62.93 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.957 0.884 . . . . 0.0 109.579 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.72 -32.3 14.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 25.8 mmt -63.62 -45.39 90.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.737 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -122.27 88.57 48.75 Favored Pre-proline 0 N--CA 1.407 -2.587 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.352 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -84.84 10.5 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.082 1.854 . . . . 0.0 109.431 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 mm -93.71 -19.87 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t . . . . . 0 C--N 1.284 -2.248 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.406 179.467 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.239 0.534 0 CA-C-O 121.393 0.616 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -117.24 108.41 43.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -39.26 -55.39 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 125.254 3.969 . . . . 0.0 115.474 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -24.11 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.467 0.651 . . . . 0.0 111.176 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.26 -11.56 27.72 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.457 0.646 . . . . 0.0 110.094 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -64.2 -11.64 32.87 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.423 0.63 . . . . 0.0 110.231 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.52 -16.53 42.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.219 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.7 tpt -80.65 -35.24 34.11 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.027 0.917 . . . . 0.0 108.735 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -131.4 89.28 41.3 Favored Pre-proline 0 C--N 1.285 -2.218 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.572 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.05 3.83 7.51 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.283 1.989 . . . . 0.0 111.143 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.1 mm -106.32 1.28 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 122.463 1.125 . . . . 0.0 109.091 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.302 -1.461 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.351 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -131.25 110.81 15.31 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.35 -44.52 4.2 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 C-N-CA 124.928 3.752 . . . . 0.0 114.366 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.72 -40.32 84.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.012 0.435 . . . . 0.0 111.4 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.0 m -87.07 -37.33 17.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -65.18 -20.54 66.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.092 0.557 . . . . 0.0 112.368 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.5 -36.44 29.26 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -65.55 -43.3 90.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.177 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -139.89 105.54 6.83 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.461 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.72 -10.97 25.65 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.516 2.144 . . . . 0.0 111.484 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.9 mt -67.99 -29.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 122.541 1.163 . . . . 0.0 109.085 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.271 -2.817 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.805 179.118 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.442 -0.848 0 CA-C-O 120.778 0.323 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -127.11 109.18 21.65 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 121.859 -0.525 . . . . 0.0 109.637 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -40.17 -38.86 2.31 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 C-N-CA 125.104 3.869 . . . . 0.0 115.42 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.38 -37.84 78.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.089 0.471 . . . . 0.0 111.203 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.93 -23.22 16.43 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.489 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 p -70.92 -28.38 64.46 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.348 0.594 . . . . 0.0 109.888 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.53 -14.57 34.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.826 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.4 ttt -73.33 -46.96 46.34 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 t -119.81 90.49 43.68 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.42 3.55 3.02 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 112.677 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.4 mt -70.3 -31.74 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.478 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 t . . . . . 0 C--N 1.279 -2.494 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.959 -179.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.444 -0.733 0 CA-C-O 121.473 0.654 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -117.9 128.46 25.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -37.24 -47.7 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 124.809 3.672 . . . . 0.0 115.533 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.82 -39.35 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 11' ' ' MET . 85.8 m -69.37 -38.91 78.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.304 0.574 . . . . 0.0 110.222 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -67.56 -19.54 65.29 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.911 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.49 -40.31 13.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.802 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 22.4 ptp -70.39 -28.46 65.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.333 0.587 . . . . 0.0 110.546 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -136.16 89.11 20.45 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.766 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.98 1.93 8.43 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.975 1.783 . . . . 0.0 110.762 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.34 -12.05 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.532 1.158 . . . . 0.0 108.643 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.9 t . . . . . 0 C--N 1.294 -1.807 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.966 177.184 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -131.52 122.78 19.04 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.038 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -35.52 -60.74 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.047 1 C-N-CA 125.329 4.019 . . . . 0.0 116.078 -174.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 11' ' ' MET . 13.8 p -69.12 -35.59 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.0 m -73.08 -41.49 64.03 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.223 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 22.7 m -69.88 -8.83 51.83 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.44 -39.58 11.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.4 mmt -64.34 -39.35 93.71 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.006 0.908 . . . . 0.0 109.626 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t -130.22 92.87 34.72 Favored Pre-proline 0 C--N 1.274 -2.682 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.157 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 9' ' ' SER . 57.3 Cg_endo -76.7 3.82 6.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.203 1.936 . . . . 0.0 111.559 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mt -85.22 -15.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.453 1.12 . . . . 0.0 108.819 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 C--N 1.289 -2.064 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.429 -179.098 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 121.665 0.745 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -88.04 132.47 39.76 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.63 -59.53 1.1 Allowed 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 123.157 2.571 . . . . 0.0 111.807 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 75.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t 176.66 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.69 -1.595 . . . . 0.0 107.886 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -63.33 -33.66 76.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.751 0.786 . . . . 0.0 109.478 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.92 -24.11 52.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.347 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.6 mmt -84.88 -35.1 22.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.486 0.66 . . . . 0.0 110.393 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -137.7 90.1 14.81 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.88 3.4 7.0 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.133 1.888 . . . . 0.0 110.185 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.1 mt -75.52 -19.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.012 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.285 -2.2 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.632 -178.544 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.565 ' CD2' ' HD2' ' A' ' 6' ' ' PRO . 10.9 t-80 -141.26 132.94 13.7 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 5' ' ' HIS . 1.3 Cg_exo -30.37 -46.88 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.027 1 C-N-CA 125.688 4.258 . . . . 0.0 116.032 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -51.54 -41.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.0 m -104.36 -24.96 13.02 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.759 -0.588 . . . . 0.0 111.068 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -65.85 -35.19 79.98 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.192 0.52 . . . . 0.0 111.548 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 -9.61 47.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.505 0.669 . . . . 0.0 110.137 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -83.09 -48.48 10.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.172 0.987 . . . . 0.0 108.534 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 t -135.48 94.89 14.9 Favored Pre-proline 0 N--CA 1.403 -2.808 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.067 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.47 4.47 5.47 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.377 2.051 . . . . 0.0 110.604 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.4 mt -84.3 -23.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.357 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.9 t . . . . . 0 C--N 1.281 -2.405 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.535 -175.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 121.363 0.601 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -120.8 127.3 26.31 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.393 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -23.61 -57.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 1 C-N-CA 127.01 5.14 . . . . 0.0 117.077 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.62 -41.94 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -83.61 -27.74 28.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -64.06 -36.88 85.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.205 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.74 50.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 tpt -61.68 -42.92 99.59 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.721 0.772 . . . . 0.0 110.869 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -133.01 95.86 18.37 Favored Pre-proline 0 C--N 1.271 -2.816 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.933 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -76.45 -6.07 16.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.949 1.766 . . . . 0.0 110.744 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.4 mt -81.36 -30.78 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 122.789 1.281 . . . . 0.0 107.991 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t . . . . . 0 C--N 1.27 -2.868 0 CA-C-N 112.596 -2.093 . . . . 0.0 109.223 -177.13 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 120.964 0.411 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -89.87 113.17 55.98 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -33.85 -65.37 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.341 1 C-N-CA 125.54 4.16 . . . . 0.0 116.362 -171.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.13 -40.74 88.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.8 t -74.03 -23.32 59.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.977 0.418 . . . . 0.0 110.572 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -72.78 -17.06 61.62 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 121.855 0.836 . . . . 0.0 108.979 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.3 -22.29 18.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mmt -73.3 -33.39 65.17 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.822 0.82 . . . . 0.0 109.186 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.9 t -131.77 92.46 30.51 Favored Pre-proline 0 N--CA 1.412 -2.366 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.205 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.13 4.43 6.21 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.396 2.064 . . . . 0.0 110.264 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.4 -28.32 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.029 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.279 -2.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.047 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -122.24 137.64 27.86 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.28 -43.78 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.406 1 C-N-CA 125.462 4.108 . . . . 0.0 115.317 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.432 ' O ' ' HG3' ' A' ' 11' ' ' MET . 80.9 t -50.74 -65.72 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.748 0.655 . . . . 0.0 111.715 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 78.8 m -82.65 -23.76 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -64.37 -34.71 78.8 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.87 -23.68 31.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.701 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 7' ' ' VAL . 66.6 mtt -70.22 -51.51 30.31 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.046 0.927 . . . . 0.0 109.084 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -123.11 104.47 35.27 Favored Pre-proline 0 N--CA 1.406 -2.66 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.033 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -78.78 -11.76 15.19 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.187 1.925 . . . . 0.0 109.371 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.43 -30.76 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.898 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.8 t . . . . . 0 C--N 1.27 -2.85 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.746 -178.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.1 p . . . . . 0 N--CA 1.434 -1.236 0 CA-C-O 120.454 0.169 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -135.32 113.52 11.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_exo -29.62 -61.64 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.028 1 C-N-CA 126.26 4.64 . . . . 0.0 116.607 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.14 -34.46 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -90.1 -20.85 22.66 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.368 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 m -72.15 -25.03 61.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.78 -39.76 26.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.882 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -61.6 -44.11 97.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.004 0.906 . . . . 0.0 110.294 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -120.79 89.01 44.82 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.619 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.34 3.78 7.51 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.905 1.737 . . . . 0.0 108.807 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.49 -31.25 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 113.881 -1.508 . . . . 0.0 107.497 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--N 1.278 -2.538 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.865 177.099 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.548 0.895 0 CA-C-O 121.529 0.681 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -123.8 106.09 32.07 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -37.82 -52.25 1.72 Allowed 'Trans proline' 0 N--CA 1.488 1.164 1 C-N-CA 125.503 4.136 . . . . 0.0 116.098 -173.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.25 -39.64 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.9 t -84.83 -19.75 31.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.45 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -66.23 -13.55 60.52 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.027 0.441 . . . . 0.0 110.886 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.02 -20.43 55.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.379 . . . . 0.0 109.981 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.5 mmt -76.2 -35.03 59.28 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.68 0.753 . . . . 0.0 109.353 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -127.18 86.38 58.91 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.5 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -74.36 -4.63 15.71 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.675 1.583 . . . . 0.0 110.04 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.88 -14.47 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.113 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.287 -2.141 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.604 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.429 -1.497 0 CA-C-O 121.219 0.533 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -127.8 127.51 23.96 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.0 -45.95 23.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.782 2.988 . . . . 0.0 113.961 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.28 -49.01 79.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.551 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.7 m -72.33 -33.52 67.39 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.142 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -70.58 -15.46 62.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 120.96 0.409 . . . . 0.0 110.793 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.43 -34.95 18.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.6 mmm -72.19 -35.51 68.97 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.746 0.784 . . . . 0.0 109.911 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -127.53 87.48 56.02 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.959 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.97 11.06 3.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.548 2.165 . . . . 0.0 110.365 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.97 -19.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.662 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--N 1.288 -2.078 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.859 -177.848 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.802 0.811 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t . . . . . 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.069 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 3.8 t -67.98 -40.75 83.08 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.1 m -66.32 -0.39 2.59 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.975 0.91 . . . . 0.0 113.018 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -97.55 5.9 48.86 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.155 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -131.94 125.02 19.99 Favored Pre-proline 0 N--CA 1.435 -1.206 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -25.25 -53.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 1 C-N-CA 126.601 4.867 . . . . 0.0 117.39 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 11' ' ' MET . 27.7 m -65.05 -42.64 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 4.2 m -76.81 -31.23 56.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -64.63 -26.03 68.22 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.037 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.71 -15.3 35.16 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.121 0.486 . . . . 0.0 110.595 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.6 mmt -74.32 -51.59 14.72 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -130.38 100.96 17.84 Favored Pre-proline 0 C--N 1.278 -2.535 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.985 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -3.16 12.9 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.197 1.931 . . . . 0.0 111.237 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -92.98 -10.1 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 122.697 1.237 . . . . 0.0 108.581 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.0 t -95.4 102.47 14.27 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 113.983 -1.462 . . . . 0.0 108.557 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.03 0 CA-C-N 116.39 -0.368 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.932 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.8 t -68.58 -41.8 79.17 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.14 -3.42 29.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.332 0.587 . . . . 0.0 112.125 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m -95.69 4.81 52.67 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.817 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t -90.31 85.24 6.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.323 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 2.8 t -142.23 -48.39 0.36 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.6 m -56.86 -25.28 56.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.489 0.716 . . . . 0.0 112.773 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.0 m -90.03 18.74 5.51 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.259 0.552 . . . . 0.0 110.936 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -131.57 126.53 21.13 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -28.81 -54.1 0.15 Allowed 'Trans proline' 0 C--N 1.368 1.569 1 C-N-CA 126.133 4.555 . . . . 0.0 116.086 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.76 -36.0 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 3.5 m -90.81 -22.72 20.87 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -69.24 -29.2 67.07 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.271 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.99 -28.88 25.48 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.032 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.0 ttt -60.09 -54.13 49.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.137 0.97 . . . . 0.0 109.134 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -133.55 97.41 15.93 Favored Pre-proline 0 C--N 1.272 -2.796 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.882 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.06 3.44 6.15 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.762 2.308 . . . . 0.0 112.387 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.9 mm -97.78 -10.41 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.524 1.154 . . . . 0.0 108.041 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t -111.69 -60.27 1.87 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.848 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.755 0 CA-C-N 116.352 -0.385 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.072 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.8 p -97.64 -69.01 0.77 Allowed 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.8 t 68.85 -61.51 0.42 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.159 1.384 . . . . 0.0 113.021 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 m -90.37 28.86 1.36 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.233 0.54 . . . . 0.0 112.263 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -125.82 110.03 25.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -40.85 -50.4 4.05 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 125.009 3.806 . . . . 0.0 115.449 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.5 t -66.59 -31.61 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.811 0.815 . . . . 0.0 110.353 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.1 t -87.77 -17.15 32.28 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.987 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 m -67.74 -16.98 64.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.694 0.759 . . . . 0.0 110.291 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.99 -22.52 20.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.27 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.4 mmm -77.36 -39.42 47.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -125.51 87.58 55.52 Favored Pre-proline 0 C--N 1.273 -2.717 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.83 4.33 3.21 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.4 -32.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.348 1.07 . . . . 0.0 108.189 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.1 t -119.95 91.56 3.57 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.998 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.956 0 CA-C-N 116.259 -0.428 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.57 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.423 ' C ' ' HB2' ' A' ' 8' ' ' CYS . 3.0 t -68.01 -49.13 63.38 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 82.7 m -72.15 -1.91 16.73 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.764 0.826 . . . . 0.0 112.835 -175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m -89.05 3.54 51.39 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.169 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -138.2 129.63 15.8 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -28.16 -48.33 0.11 Allowed 'Trans proline' 0 C--N 1.369 1.635 1 C-N-CA 126.553 4.835 . . . . 0.0 116.162 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.475 HG22 ' SG ' ' A' ' 8' ' ' CYS . 31.4 m -55.62 -32.24 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.475 ' SG ' HG22 ' A' ' 7' ' ' VAL . 4.6 m -107.72 -21.99 12.66 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.559 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -63.53 -39.27 93.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 110.426 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.6 -20.64 33.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.87 -47.75 76.72 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.982 0.896 . . . . 0.0 109.438 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.4 t -135.48 97.43 13.02 Favored Pre-proline 0 C--N 1.277 -2.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.543 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.85 -1.75 11.25 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.268 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.25 -28.66 6.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 123.032 1.396 . . . . 0.0 107.711 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t -90.79 -58.14 2.58 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 112.451 -2.159 . . . . 0.0 109.643 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.804 0 O-C-N 121.998 -0.439 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.695 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 p -132.32 176.56 8.3 Favored 'General case' 1 N--CA 1.359 -5.009 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 53.2 t -165.35 -53.99 0.03 OUTLIER 'General case' 0 C--N 1.256 -3.493 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.933 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p -88.49 19.68 3.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.484 0.659 . . . . 0.0 111.798 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -101.98 120.47 53.78 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -37.43 -55.99 0.92 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.636 3.557 . . . . 0.0 115.983 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 11' ' ' MET . 33.2 m -67.54 -28.99 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.472 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.05 -24.25 47.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -18.22 62.93 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.957 0.884 . . . . 0.0 109.579 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.72 -32.3 14.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 25.8 mmt -63.62 -45.39 90.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.737 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -122.27 88.57 48.75 Favored Pre-proline 0 N--CA 1.407 -2.587 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.352 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -84.84 10.5 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.082 1.854 . . . . 0.0 109.431 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 mm -93.71 -19.87 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t -107.51 -75.56 0.63 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.406 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.778 0 O-C-N 121.932 -0.48 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.586 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.3 p -114.58 -67.55 0.99 Allowed 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.342 0.591 . . . . 0.0 110.996 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.3 t 66.74 -63.39 0.26 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.535 1.934 . . . . 0.0 113.555 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 m -79.86 19.12 0.71 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.761 0.824 . . . . 0.0 112.457 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -117.24 108.41 43.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -39.26 -55.39 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 125.254 3.969 . . . . 0.0 115.474 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -24.11 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.467 0.651 . . . . 0.0 111.176 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.26 -11.56 27.72 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.457 0.646 . . . . 0.0 110.094 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -64.2 -11.64 32.87 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.423 0.63 . . . . 0.0 110.231 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.52 -16.53 42.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.219 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.7 tpt -80.65 -35.24 34.11 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.027 0.917 . . . . 0.0 108.735 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -131.4 89.28 41.3 Favored Pre-proline 0 C--N 1.285 -2.218 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.572 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.05 3.83 7.51 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.283 1.989 . . . . 0.0 111.143 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.1 mm -106.32 1.28 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 122.463 1.125 . . . . 0.0 109.091 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.6 t -86.3 -85.53 0.16 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.351 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.967 0 O-C-N 121.85 -0.532 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 1.8 m -64.94 -29.05 69.96 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -177.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.2 m -69.13 -11.75 61.07 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.429 0.633 . . . . 0.0 111.623 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -129.16 29.97 5.08 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 2' ' ' CYS . 12.1 t-80 -131.25 110.81 15.31 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.35 -44.52 4.2 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 C-N-CA 124.928 3.752 . . . . 0.0 114.366 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.72 -40.32 84.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.012 0.435 . . . . 0.0 111.4 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.0 m -87.07 -37.33 17.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -65.18 -20.54 66.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.092 0.557 . . . . 0.0 112.368 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.5 -36.44 29.26 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -65.55 -43.3 90.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.177 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -139.89 105.54 6.83 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.461 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.72 -10.97 25.65 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.516 2.144 . . . . 0.0 111.484 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.9 mt -67.99 -29.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 122.541 1.163 . . . . 0.0 109.085 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.4 t -97.27 90.0 4.95 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.805 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 116.283 -0.417 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.907 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.0 m -65.24 -40.29 93.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.0 -14.57 62.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.619 0.723 . . . . 0.0 110.967 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -109.53 8.54 25.18 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.409 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -127.11 109.18 21.65 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 121.859 -0.525 . . . . 0.0 109.637 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -40.17 -38.86 2.31 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 C-N-CA 125.104 3.869 . . . . 0.0 115.42 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.38 -37.84 78.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.089 0.471 . . . . 0.0 111.203 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.93 -23.22 16.43 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.489 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 p -70.92 -28.38 64.46 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.348 0.594 . . . . 0.0 109.888 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.53 -14.57 34.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.826 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.4 ttt -73.33 -46.96 46.34 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 t -119.81 90.49 43.68 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.42 3.55 3.02 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 112.677 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.4 mt -70.3 -31.74 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.478 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 t -132.9 88.17 2.48 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.959 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 116.394 -0.366 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.882 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.5 p -87.46 -74.54 0.44 Allowed 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.8 t 64.07 -46.38 0.28 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.508 1.523 . . . . 0.0 114.085 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 t -94.83 29.49 2.35 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.367 0.667 . . . . 0.0 110.5 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -117.9 128.46 25.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -37.24 -47.7 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 124.809 3.672 . . . . 0.0 115.533 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.82 -39.35 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 11' ' ' MET . 85.8 m -69.37 -38.91 78.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.304 0.574 . . . . 0.0 110.222 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -67.56 -19.54 65.29 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.911 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.49 -40.31 13.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.802 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 22.4 ptp -70.39 -28.46 65.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.333 0.587 . . . . 0.0 110.546 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -136.16 89.11 20.45 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.766 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.98 1.93 8.43 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.975 1.783 . . . . 0.0 110.762 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.34 -12.05 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.532 1.158 . . . . 0.0 108.643 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.9 t -108.86 -70.78 0.79 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.966 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.644 0 O-C-N 122.295 -0.253 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.3 m -70.99 -30.01 66.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.5 m -72.76 -2.49 20.62 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.682 0.754 . . . . 0.0 112.154 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 p -133.57 31.29 3.72 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.626 175.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -131.52 122.78 19.04 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.038 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -35.52 -60.74 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.047 1 C-N-CA 125.329 4.019 . . . . 0.0 116.078 -174.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 11' ' ' MET . 13.8 p -69.12 -35.59 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 35.0 m -73.08 -41.49 64.03 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.223 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 22.7 m -69.88 -8.83 51.83 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.44 -39.58 11.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.4 mmt -64.34 -39.35 93.71 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.006 0.908 . . . . 0.0 109.626 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t -130.22 92.87 34.72 Favored Pre-proline 0 C--N 1.274 -2.682 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.157 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 9' ' ' SER . 57.3 Cg_endo -76.7 3.82 6.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.203 1.936 . . . . 0.0 111.559 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mt -85.22 -15.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.453 1.12 . . . . 0.0 108.819 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 t -145.94 87.56 1.77 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.429 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 116.544 -0.298 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.273 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.4 p -83.93 -70.01 0.6 Allowed 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.038 0.447 . . . . 0.0 110.978 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.1 t 63.1 -69.17 0.07 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 126.344 1.858 . . . . 0.0 113.741 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -90.8 15.6 10.92 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.665 0.745 . . . . 0.0 110.492 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -88.04 132.47 39.76 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.63 -59.53 1.1 Allowed 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 123.157 2.571 . . . . 0.0 111.807 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 75.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t 176.66 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.69 -1.595 . . . . 0.0 107.886 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -63.33 -33.66 76.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.751 0.786 . . . . 0.0 109.478 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.92 -24.11 52.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.347 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.6 mmt -84.88 -35.1 22.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.486 0.66 . . . . 0.0 110.393 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -137.7 90.1 14.81 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.88 3.4 7.0 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.133 1.888 . . . . 0.0 110.185 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.1 mt -75.52 -19.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.012 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t -91.12 90.61 7.89 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.632 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.141 0 O-C-N 122.149 -0.344 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.644 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.5 t -66.12 -33.49 75.91 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.385 0.612 . . . . 0.0 109.642 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.2 m -71.73 -11.07 60.64 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.344 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.6 m -94.91 14.68 20.84 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.905 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.565 ' CD2' ' HD2' ' A' ' 6' ' ' PRO . 10.9 t-80 -141.26 132.94 13.7 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 5' ' ' HIS . 1.3 Cg_exo -30.37 -46.88 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.027 1 C-N-CA 125.688 4.258 . . . . 0.0 116.032 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -51.54 -41.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.0 m -104.36 -24.96 13.02 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.759 -0.588 . . . . 0.0 111.068 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -65.85 -35.19 79.98 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.192 0.52 . . . . 0.0 111.548 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 -9.61 47.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.505 0.669 . . . . 0.0 110.137 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -83.09 -48.48 10.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.172 0.987 . . . . 0.0 108.534 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 t -135.48 94.89 14.9 Favored Pre-proline 0 N--CA 1.403 -2.808 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.067 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.47 4.47 5.47 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.377 2.051 . . . . 0.0 110.604 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.4 mt -84.3 -23.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.357 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.9 t -88.07 95.89 10.31 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.535 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.084 0 CA-C-N 116.25 -0.432 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.0 t -89.12 -49.22 6.88 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.0 m -68.0 -10.1 50.93 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.681 0.792 . . . . 0.0 113.066 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 p -88.61 -1.09 57.88 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.363 0.601 . . . . 0.0 109.948 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -120.8 127.3 26.31 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.393 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -23.61 -57.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 1 C-N-CA 127.01 5.14 . . . . 0.0 117.077 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.62 -41.94 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -83.61 -27.74 28.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -64.06 -36.88 85.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.205 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.74 50.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 tpt -61.68 -42.92 99.59 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.721 0.772 . . . . 0.0 110.869 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -133.01 95.86 18.37 Favored Pre-proline 0 C--N 1.271 -2.816 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.933 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -76.45 -6.07 16.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.949 1.766 . . . . 0.0 110.744 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.4 mt -81.36 -30.78 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 122.789 1.281 . . . . 0.0 107.991 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t -90.49 -58.15 2.59 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 112.596 -2.093 . . . . 0.0 109.223 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.652 0 O-C-N 122.354 -0.216 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.728 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.1 p -78.86 -65.22 1.02 Allowed 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 117.269 0.535 . . . . 0.0 109.57 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.6 t 63.95 -60.87 0.18 Allowed 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 126.165 1.786 . . . . 0.0 115.029 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -94.44 4.03 54.38 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.821 -0.549 . . . . 0.0 111.104 -174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -89.87 113.17 55.98 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -33.85 -65.37 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.341 1 C-N-CA 125.54 4.16 . . . . 0.0 116.362 -171.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.13 -40.74 88.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.8 t -74.03 -23.32 59.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.977 0.418 . . . . 0.0 110.572 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -72.78 -17.06 61.62 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 121.855 0.836 . . . . 0.0 108.979 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.3 -22.29 18.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mmt -73.3 -33.39 65.17 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.822 0.82 . . . . 0.0 109.186 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.9 t -131.77 92.46 30.51 Favored Pre-proline 0 N--CA 1.412 -2.366 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.205 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.13 4.43 6.21 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.396 2.064 . . . . 0.0 110.264 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.4 -28.32 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.029 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -126.11 -57.26 1.42 Allowed 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.047 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 O-C-N 122.222 -0.299 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.0 t -86.11 -33.09 21.01 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 120.961 0.41 . . . . 0.0 110.27 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 70.8 m -64.83 -15.13 61.4 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.438 0.637 . . . . 0.0 111.843 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t -97.53 3.8 50.55 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -122.24 137.64 27.86 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.28 -43.78 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.406 1 C-N-CA 125.462 4.108 . . . . 0.0 115.317 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.432 ' O ' ' HG3' ' A' ' 11' ' ' MET . 80.9 t -50.74 -65.72 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.748 0.655 . . . . 0.0 111.715 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 78.8 m -82.65 -23.76 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -64.37 -34.71 78.8 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.87 -23.68 31.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.701 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 7' ' ' VAL . 66.6 mtt -70.22 -51.51 30.31 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.046 0.927 . . . . 0.0 109.084 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -123.11 104.47 35.27 Favored Pre-proline 0 N--CA 1.406 -2.66 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.033 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -78.78 -11.76 15.19 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.187 1.925 . . . . 0.0 109.371 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.43 -30.76 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.898 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 34.8 t -94.1 89.31 5.96 Favored 'General case' 0 C--N 1.27 -2.85 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.746 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.237 0 CA-C-N 116.528 -0.305 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.492 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.37 -38.58 91.54 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.1 m -77.45 -6.53 53.79 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.554 0.692 . . . . 0.0 111.243 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.1 p -121.99 15.92 10.82 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.134 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -135.32 113.52 11.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_exo -29.62 -61.64 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.028 1 C-N-CA 126.26 4.64 . . . . 0.0 116.607 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.14 -34.46 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -90.1 -20.85 22.66 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.368 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 m -72.15 -25.03 61.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.78 -39.76 26.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.882 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -61.6 -44.11 97.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.004 0.906 . . . . 0.0 110.294 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -120.79 89.01 44.82 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.619 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.34 3.78 7.51 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.905 1.737 . . . . 0.0 108.807 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.49 -31.25 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 113.881 -1.508 . . . . 0.0 107.497 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t -102.06 -70.28 0.76 Allowed 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.865 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 O-C-N 122.189 -0.319 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.422 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.5 m -68.33 -31.99 71.79 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.4 t -74.69 -7.97 54.92 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.697 0.761 . . . . 0.0 110.14 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t -118.14 8.27 12.35 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.787 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -123.8 106.09 32.07 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -37.82 -52.25 1.72 Allowed 'Trans proline' 0 N--CA 1.488 1.164 1 C-N-CA 125.503 4.136 . . . . 0.0 116.098 -173.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.25 -39.64 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.9 t -84.83 -19.75 31.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.45 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -66.23 -13.55 60.52 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.027 0.441 . . . . 0.0 110.886 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.02 -20.43 55.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.379 . . . . 0.0 109.981 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.5 mmt -76.2 -35.03 59.28 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.68 0.753 . . . . 0.0 109.353 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -127.18 86.38 58.91 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.5 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -74.36 -4.63 15.71 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.675 1.583 . . . . 0.0 110.04 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.88 -14.47 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.113 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.0 t -105.77 -77.86 0.58 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.736 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.18 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.2 m -82.3 -38.95 23.59 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.8 m -67.84 -15.85 63.82 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.951 0.881 . . . . 0.0 110.224 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.8 p -109.46 20.2 18.47 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.825 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -127.8 127.51 23.96 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.0 -45.95 23.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.782 2.988 . . . . 0.0 113.961 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.28 -49.01 79.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.551 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 36.7 m -72.33 -33.52 67.39 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.142 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -70.58 -15.46 62.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 120.96 0.409 . . . . 0.0 110.793 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.43 -34.95 18.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.6 mmm -72.19 -35.51 68.97 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.746 0.784 . . . . 0.0 109.911 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -127.53 87.48 56.02 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.959 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.97 11.06 3.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.548 2.165 . . . . 0.0 110.365 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.97 -19.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.662 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t -128.78 90.82 3.11 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.859 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.961 0 O-C-N 122.157 -0.339 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.932 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.8 t -68.58 -41.8 79.17 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.14 -3.42 29.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.332 0.587 . . . . 0.0 112.125 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m -95.69 4.81 52.67 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.817 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t -90.31 85.24 6.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.442 -0.826 0 CA-C-O 121.553 0.692 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -131.94 125.02 19.99 Favored Pre-proline 0 N--CA 1.435 -1.206 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -25.25 -53.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 1 C-N-CA 126.601 4.867 . . . . 0.0 117.39 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 11' ' ' MET . 27.7 m -65.05 -42.64 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 m -76.81 -31.23 56.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -64.63 -26.03 68.22 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.037 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.71 -15.3 35.16 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.121 0.486 . . . . 0.0 110.595 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.6 mmt -74.32 -51.59 14.72 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -130.38 100.96 17.84 Favored Pre-proline 0 C--N 1.278 -2.535 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.985 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -3.16 12.9 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.197 1.931 . . . . 0.0 111.237 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -92.98 -10.1 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 122.697 1.237 . . . . 0.0 108.581 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.286 -2.166 0 CA-C-N 113.983 -1.462 . . . . 0.0 108.557 179.513 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.802 0.811 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t . . . . . 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 121.259 0.552 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -131.57 126.53 21.13 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -28.81 -54.1 0.15 Allowed 'Trans proline' 0 C--N 1.368 1.569 1 C-N-CA 126.133 4.555 . . . . 0.0 116.086 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.76 -36.0 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.81 -22.72 20.87 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -69.24 -29.2 67.07 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.271 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.99 -28.88 25.48 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.032 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.0 ttt -60.09 -54.13 49.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.137 0.97 . . . . 0.0 109.134 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -133.55 97.41 15.93 Favored Pre-proline 0 C--N 1.272 -2.796 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.882 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.06 3.44 6.15 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.762 2.308 . . . . 0.0 112.387 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.9 mm -97.78 -10.41 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.524 1.154 . . . . 0.0 108.041 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t . . . . . 0 C--N 1.29 -1.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.848 -177.703 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.233 0.54 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -125.82 110.03 25.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -40.85 -50.4 4.05 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 125.009 3.806 . . . . 0.0 115.449 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.5 t -66.59 -31.61 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.811 0.815 . . . . 0.0 110.353 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.1 t -87.77 -17.15 32.28 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.987 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 m -67.74 -16.98 64.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.694 0.759 . . . . 0.0 110.291 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.99 -22.52 20.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.27 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.4 mmm -77.36 -39.42 47.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -125.51 87.58 55.52 Favored Pre-proline 0 C--N 1.273 -2.717 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.83 4.33 3.21 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.4 -32.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.348 1.07 . . . . 0.0 108.189 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.279 -2.494 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.998 176.707 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -138.2 129.63 15.8 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -28.16 -48.33 0.11 Allowed 'Trans proline' 0 C--N 1.369 1.635 1 C-N-CA 126.553 4.835 . . . . 0.0 116.162 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.525 HG23 ' SG ' ' A' ' 8' ' ' CYS . 31.4 m -55.62 -32.24 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 7' ' ' VAL . 4.6 m -107.72 -21.99 12.66 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.559 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -63.53 -39.27 93.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 110.426 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.6 -20.64 33.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.87 -47.75 76.72 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.982 0.896 . . . . 0.0 109.438 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.4 t -135.48 97.43 13.02 Favored Pre-proline 0 C--N 1.277 -2.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.543 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.85 -1.75 11.25 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.268 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.25 -28.66 6.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 123.032 1.396 . . . . 0.0 107.711 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 C--N 1.273 -2.738 0 CA-C-N 112.451 -2.159 . . . . 0.0 109.643 -177.152 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.226 -0.182 0 CA-C-O 121.484 0.659 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -101.98 120.47 53.78 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -37.43 -55.99 0.92 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.636 3.557 . . . . 0.0 115.983 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 11' ' ' MET . 33.2 m -67.54 -28.99 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.472 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.05 -24.25 47.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -18.22 62.93 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.957 0.884 . . . . 0.0 109.579 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.72 -32.3 14.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 25.8 mmt -63.62 -45.39 90.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.737 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -122.27 88.57 48.75 Favored Pre-proline 0 N--CA 1.407 -2.587 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.352 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -84.84 10.5 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.082 1.854 . . . . 0.0 109.431 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 mm -93.71 -19.87 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t . . . . . 0 C--N 1.284 -2.248 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.406 179.467 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.239 0.534 0 CA-C-O 121.393 0.616 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -117.24 108.41 43.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -39.26 -55.39 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 125.254 3.969 . . . . 0.0 115.474 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -24.11 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.467 0.651 . . . . 0.0 111.176 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.26 -11.56 27.72 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.457 0.646 . . . . 0.0 110.094 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -64.2 -11.64 32.87 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.423 0.63 . . . . 0.0 110.231 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.52 -16.53 42.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.219 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.7 tpt -80.65 -35.24 34.11 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.027 0.917 . . . . 0.0 108.735 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -131.4 89.28 41.3 Favored Pre-proline 0 C--N 1.285 -2.218 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.572 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.05 3.83 7.51 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.283 1.989 . . . . 0.0 111.143 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.1 mm -106.32 1.28 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 122.463 1.125 . . . . 0.0 109.091 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.302 -1.461 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.351 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -131.25 110.81 15.31 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.35 -44.52 4.2 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 C-N-CA 124.928 3.752 . . . . 0.0 114.366 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.72 -40.32 84.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.012 0.435 . . . . 0.0 111.4 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.0 m -87.07 -37.33 17.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -65.18 -20.54 66.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.092 0.557 . . . . 0.0 112.368 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.5 -36.44 29.26 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -65.55 -43.3 90.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.177 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -139.89 105.54 6.83 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.461 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.72 -10.97 25.65 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.516 2.144 . . . . 0.0 111.484 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.9 mt -67.99 -29.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 122.541 1.163 . . . . 0.0 109.085 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.271 -2.817 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.805 179.118 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.442 -0.848 0 CA-C-O 120.778 0.323 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -127.11 109.18 21.65 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 121.859 -0.525 . . . . 0.0 109.637 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -40.17 -38.86 2.31 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 C-N-CA 125.104 3.869 . . . . 0.0 115.42 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.38 -37.84 78.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.089 0.471 . . . . 0.0 111.203 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.93 -23.22 16.43 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.489 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 p -70.92 -28.38 64.46 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.348 0.594 . . . . 0.0 109.888 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.53 -14.57 34.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.826 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.4 ttt -73.33 -46.96 46.34 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 t -119.81 90.49 43.68 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.42 3.55 3.02 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 112.677 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.4 mt -70.3 -31.74 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.478 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 t . . . . . 0 C--N 1.279 -2.494 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.959 -179.297 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.444 -0.733 0 CA-C-O 121.473 0.654 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -117.9 128.46 25.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -37.24 -47.7 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 124.809 3.672 . . . . 0.0 115.533 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.82 -39.35 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 11' ' ' MET . 85.8 m -69.37 -38.91 78.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.304 0.574 . . . . 0.0 110.222 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -67.56 -19.54 65.29 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.911 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.49 -40.31 13.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.802 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 22.4 ptp -70.39 -28.46 65.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.333 0.587 . . . . 0.0 110.546 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -136.16 89.11 20.45 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.766 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.98 1.93 8.43 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.975 1.783 . . . . 0.0 110.762 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.34 -12.05 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.532 1.158 . . . . 0.0 108.643 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.9 t . . . . . 0 C--N 1.294 -1.807 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.966 177.184 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.411 ' CE1' HG12 ' A' ' 7' ' ' VAL . 56.3 t-80 -131.52 122.78 19.04 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.038 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -35.52 -60.74 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.047 1 C-N-CA 125.329 4.019 . . . . 0.0 116.078 -174.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' A' ' 11' ' ' MET . 13.8 p -69.12 -35.59 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.0 m -73.08 -41.49 64.03 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.223 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 22.7 m -69.88 -8.83 51.83 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.44 -39.58 11.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.4 mmt -64.34 -39.35 93.71 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.006 0.908 . . . . 0.0 109.626 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t -130.22 92.87 34.72 Favored Pre-proline 0 C--N 1.274 -2.682 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.157 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' SER . 57.3 Cg_endo -76.7 3.82 6.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.203 1.936 . . . . 0.0 111.559 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mt -85.22 -15.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.453 1.12 . . . . 0.0 108.819 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 C--N 1.289 -2.064 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.429 -179.098 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 121.665 0.745 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -88.04 132.47 39.76 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.63 -59.53 1.1 Allowed 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 123.157 2.571 . . . . 0.0 111.807 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 75.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t 176.66 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.69 -1.595 . . . . 0.0 107.886 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -63.33 -33.66 76.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.751 0.786 . . . . 0.0 109.478 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.92 -24.11 52.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.347 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.6 mmt -84.88 -35.1 22.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.486 0.66 . . . . 0.0 110.393 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -137.7 90.1 14.81 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.88 3.4 7.0 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.133 1.888 . . . . 0.0 110.185 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.1 mt -75.52 -19.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.012 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.285 -2.2 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.632 -178.544 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' CD2' ' HD2' ' A' ' 6' ' ' PRO . 10.9 t-80 -141.26 132.94 13.7 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 5' ' ' HIS . 1.3 Cg_exo -30.37 -46.88 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.027 1 C-N-CA 125.688 4.258 . . . . 0.0 116.032 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -51.54 -41.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.0 m -104.36 -24.96 13.02 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.759 -0.588 . . . . 0.0 111.068 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -65.85 -35.19 79.98 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.192 0.52 . . . . 0.0 111.548 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 -9.61 47.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.505 0.669 . . . . 0.0 110.137 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -83.09 -48.48 10.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.172 0.987 . . . . 0.0 108.534 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 t -135.48 94.89 14.9 Favored Pre-proline 0 N--CA 1.403 -2.808 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.067 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.47 4.47 5.47 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.377 2.051 . . . . 0.0 110.604 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.4 mt -84.3 -23.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.357 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.9 t . . . . . 0 C--N 1.281 -2.405 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.535 -175.898 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 121.363 0.601 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -120.8 127.3 26.31 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.393 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -23.61 -57.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 1 C-N-CA 127.01 5.14 . . . . 0.0 117.077 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.62 -41.94 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -83.61 -27.74 28.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -64.06 -36.88 85.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.205 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.74 50.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 tpt -61.68 -42.92 99.59 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.721 0.772 . . . . 0.0 110.869 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -133.01 95.86 18.37 Favored Pre-proline 0 C--N 1.271 -2.816 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.933 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -76.45 -6.07 16.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.949 1.766 . . . . 0.0 110.744 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.4 mt -81.36 -30.78 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 122.789 1.281 . . . . 0.0 107.991 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t . . . . . 0 C--N 1.27 -2.868 0 CA-C-N 112.596 -2.093 . . . . 0.0 109.223 -177.13 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 120.964 0.411 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -89.87 113.17 55.98 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -33.85 -65.37 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.341 1 C-N-CA 125.54 4.16 . . . . 0.0 116.362 -171.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.13 -40.74 88.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.8 t -74.03 -23.32 59.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.977 0.418 . . . . 0.0 110.572 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -72.78 -17.06 61.62 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 121.855 0.836 . . . . 0.0 108.979 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.3 -22.29 18.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mmt -73.3 -33.39 65.17 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.822 0.82 . . . . 0.0 109.186 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.9 t -131.77 92.46 30.51 Favored Pre-proline 0 N--CA 1.412 -2.366 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.205 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.13 4.43 6.21 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.396 2.064 . . . . 0.0 110.264 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.4 -28.32 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.029 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.279 -2.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.047 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -122.24 137.64 27.86 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.28 -43.78 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.406 1 C-N-CA 125.462 4.108 . . . . 0.0 115.317 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.428 ' O ' ' HG3' ' A' ' 11' ' ' MET . 80.9 t -50.74 -65.72 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.748 0.655 . . . . 0.0 111.715 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 78.8 m -82.65 -23.76 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -64.37 -34.71 78.8 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.87 -23.68 31.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.701 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 7' ' ' VAL . 66.6 mtt -70.22 -51.51 30.31 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.046 0.927 . . . . 0.0 109.084 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -123.11 104.47 35.27 Favored Pre-proline 0 N--CA 1.406 -2.66 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.033 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -78.78 -11.76 15.19 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.187 1.925 . . . . 0.0 109.371 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.43 -30.76 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.898 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.8 t . . . . . 0 C--N 1.27 -2.85 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.746 -178.998 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.1 p . . . . . 0 N--CA 1.434 -1.236 0 CA-C-O 120.454 0.169 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -135.32 113.52 11.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_exo -29.62 -61.64 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.028 1 C-N-CA 126.26 4.64 . . . . 0.0 116.607 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.14 -34.46 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -90.1 -20.85 22.66 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.368 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 m -72.15 -25.03 61.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.78 -39.76 26.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.882 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -61.6 -44.11 97.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.004 0.906 . . . . 0.0 110.294 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -120.79 89.01 44.82 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.619 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.34 3.78 7.51 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.905 1.737 . . . . 0.0 108.807 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.49 -31.25 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 113.881 -1.508 . . . . 0.0 107.497 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--N 1.278 -2.538 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.865 177.099 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.548 0.895 0 CA-C-O 121.529 0.681 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -123.8 106.09 32.07 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -37.82 -52.25 1.72 Allowed 'Trans proline' 0 N--CA 1.488 1.164 1 C-N-CA 125.503 4.136 . . . . 0.0 116.098 -173.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.25 -39.64 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.9 t -84.83 -19.75 31.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.45 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -66.23 -13.55 60.52 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.027 0.441 . . . . 0.0 110.886 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.02 -20.43 55.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.379 . . . . 0.0 109.981 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.5 mmt -76.2 -35.03 59.28 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.68 0.753 . . . . 0.0 109.353 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -127.18 86.38 58.91 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.5 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -74.36 -4.63 15.71 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.675 1.583 . . . . 0.0 110.04 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.88 -14.47 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.113 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.287 -2.141 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.604 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.429 -1.497 0 CA-C-O 121.219 0.533 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.452 ' CE1' ' HB ' ' A' ' 7' ' ' VAL . 31.8 t-80 -127.8 127.51 23.96 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.0 -45.95 23.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.782 2.988 . . . . 0.0 113.961 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 5' ' ' HIS . 62.0 t -66.28 -49.01 79.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.551 -177.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.7 m -72.33 -33.52 67.39 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.142 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -70.58 -15.46 62.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 120.96 0.409 . . . . 0.0 110.793 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.43 -34.95 18.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.6 mmm -72.19 -35.51 68.97 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.746 0.784 . . . . 0.0 109.911 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -127.53 87.48 56.02 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.959 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.97 11.06 3.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.548 2.165 . . . . 0.0 110.365 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.97 -19.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.662 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--N 1.288 -2.078 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.859 -177.848 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.802 0.811 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t . . . . . 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.069 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 3.8 t -67.98 -40.75 83.08 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.1 m -66.32 -0.39 2.59 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.975 0.91 . . . . 0.0 113.018 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -97.55 5.9 48.86 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.155 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -131.94 125.02 19.99 Favored Pre-proline 0 N--CA 1.435 -1.206 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -25.25 -53.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 1 C-N-CA 126.601 4.867 . . . . 0.0 117.39 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 11' ' ' MET . 27.7 m -65.05 -42.64 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 4.2 m -76.81 -31.23 56.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -64.63 -26.03 68.22 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.037 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.71 -15.3 35.16 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.121 0.486 . . . . 0.0 110.595 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.6 mmt -74.32 -51.59 14.72 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -130.38 100.96 17.84 Favored Pre-proline 0 C--N 1.278 -2.535 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.985 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -3.16 12.9 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.197 1.931 . . . . 0.0 111.237 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -92.98 -10.1 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 122.697 1.237 . . . . 0.0 108.581 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.0 t -95.4 102.47 14.27 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 113.983 -1.462 . . . . 0.0 108.557 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.03 0 CA-C-N 116.39 -0.368 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.932 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.8 t -68.58 -41.8 79.17 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.14 -3.42 29.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.332 0.587 . . . . 0.0 112.125 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m -95.69 4.81 52.67 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.817 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t -90.31 85.24 6.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.323 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 2.8 t -142.23 -48.39 0.36 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.6 m -56.86 -25.28 56.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.489 0.716 . . . . 0.0 112.773 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.0 m -90.03 18.74 5.51 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.259 0.552 . . . . 0.0 110.936 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -131.57 126.53 21.13 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -28.81 -54.1 0.15 Allowed 'Trans proline' 0 C--N 1.368 1.569 1 C-N-CA 126.133 4.555 . . . . 0.0 116.086 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.76 -36.0 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 3.5 m -90.81 -22.72 20.87 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -69.24 -29.2 67.07 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.271 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.99 -28.88 25.48 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.032 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.0 ttt -60.09 -54.13 49.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.137 0.97 . . . . 0.0 109.134 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -133.55 97.41 15.93 Favored Pre-proline 0 C--N 1.272 -2.796 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.882 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.06 3.44 6.15 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.762 2.308 . . . . 0.0 112.387 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.9 mm -97.78 -10.41 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.524 1.154 . . . . 0.0 108.041 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t -111.69 -60.27 1.87 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.848 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.755 0 CA-C-N 116.352 -0.385 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.072 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.8 p -97.64 -69.01 0.77 Allowed 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.8 t 68.85 -61.51 0.42 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.159 1.384 . . . . 0.0 113.021 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 m -90.37 28.86 1.36 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.233 0.54 . . . . 0.0 112.263 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -125.82 110.03 25.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -40.85 -50.4 4.05 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 125.009 3.806 . . . . 0.0 115.449 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.5 t -66.59 -31.61 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.811 0.815 . . . . 0.0 110.353 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.1 t -87.77 -17.15 32.28 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.987 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 m -67.74 -16.98 64.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.694 0.759 . . . . 0.0 110.291 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.99 -22.52 20.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.27 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.4 mmm -77.36 -39.42 47.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -125.51 87.58 55.52 Favored Pre-proline 0 C--N 1.273 -2.717 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.83 4.33 3.21 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.4 -32.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.348 1.07 . . . . 0.0 108.189 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.1 t -119.95 91.56 3.57 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.998 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.956 0 CA-C-N 116.259 -0.428 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.57 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.421 ' C ' ' HB2' ' A' ' 8' ' ' CYS . 3.0 t -68.01 -49.13 63.38 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 82.7 m -72.15 -1.91 16.73 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.764 0.826 . . . . 0.0 112.835 -175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m -89.05 3.54 51.39 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.169 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -138.2 129.63 15.8 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -28.16 -48.33 0.11 Allowed 'Trans proline' 0 C--N 1.369 1.635 1 C-N-CA 126.553 4.835 . . . . 0.0 116.162 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.525 HG23 ' SG ' ' A' ' 8' ' ' CYS . 31.4 m -55.62 -32.24 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 7' ' ' VAL . 4.6 m -107.72 -21.99 12.66 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.559 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -63.53 -39.27 93.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 110.426 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.6 -20.64 33.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.87 -47.75 76.72 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.982 0.896 . . . . 0.0 109.438 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.4 t -135.48 97.43 13.02 Favored Pre-proline 0 C--N 1.277 -2.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.543 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.85 -1.75 11.25 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.268 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.25 -28.66 6.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 123.032 1.396 . . . . 0.0 107.711 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t -90.79 -58.14 2.58 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 112.451 -2.159 . . . . 0.0 109.643 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.804 0 O-C-N 121.998 -0.439 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.695 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 p -132.32 176.56 8.3 Favored 'General case' 1 N--CA 1.359 -5.009 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 53.2 t -165.35 -53.99 0.03 OUTLIER 'General case' 0 C--N 1.256 -3.493 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.933 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p -88.49 19.68 3.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.484 0.659 . . . . 0.0 111.798 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -101.98 120.47 53.78 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -37.43 -55.99 0.92 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.636 3.557 . . . . 0.0 115.983 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 11' ' ' MET . 33.2 m -67.54 -28.99 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.472 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.05 -24.25 47.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -18.22 62.93 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.957 0.884 . . . . 0.0 109.579 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.72 -32.3 14.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 25.8 mmt -63.62 -45.39 90.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.737 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -122.27 88.57 48.75 Favored Pre-proline 0 N--CA 1.407 -2.587 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.352 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -84.84 10.5 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.082 1.854 . . . . 0.0 109.431 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 mm -93.71 -19.87 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t -107.51 -75.56 0.63 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.406 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.778 0 O-C-N 121.932 -0.48 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.586 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.3 p -114.58 -67.55 0.99 Allowed 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.342 0.591 . . . . 0.0 110.996 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.3 t 66.74 -63.39 0.26 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.535 1.934 . . . . 0.0 113.555 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 m -79.86 19.12 0.71 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.761 0.824 . . . . 0.0 112.457 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -117.24 108.41 43.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -39.26 -55.39 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 125.254 3.969 . . . . 0.0 115.474 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -24.11 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.467 0.651 . . . . 0.0 111.176 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.26 -11.56 27.72 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.457 0.646 . . . . 0.0 110.094 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -64.2 -11.64 32.87 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.423 0.63 . . . . 0.0 110.231 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.52 -16.53 42.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.219 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.7 tpt -80.65 -35.24 34.11 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.027 0.917 . . . . 0.0 108.735 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -131.4 89.28 41.3 Favored Pre-proline 0 C--N 1.285 -2.218 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.572 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.05 3.83 7.51 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.283 1.989 . . . . 0.0 111.143 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.1 mm -106.32 1.28 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 122.463 1.125 . . . . 0.0 109.091 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.6 t -86.3 -85.53 0.16 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.351 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.967 0 O-C-N 121.85 -0.532 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.545 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 1.8 m -64.94 -29.05 69.96 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -177.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.2 m -69.13 -11.75 61.07 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.429 0.633 . . . . 0.0 111.623 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -129.16 29.97 5.08 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.545 ' HB3' ' HA ' ' A' ' 2' ' ' CYS . 12.1 t-80 -131.25 110.81 15.31 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.35 -44.52 4.2 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 C-N-CA 124.928 3.752 . . . . 0.0 114.366 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.72 -40.32 84.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.012 0.435 . . . . 0.0 111.4 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.0 m -87.07 -37.33 17.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -65.18 -20.54 66.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.092 0.557 . . . . 0.0 112.368 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.5 -36.44 29.26 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -65.55 -43.3 90.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.177 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -139.89 105.54 6.83 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.461 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.72 -10.97 25.65 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.516 2.144 . . . . 0.0 111.484 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.9 mt -67.99 -29.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 122.541 1.163 . . . . 0.0 109.085 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.4 t -97.27 90.0 4.95 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.805 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 116.283 -0.417 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.907 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.0 m -65.24 -40.29 93.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.0 -14.57 62.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.619 0.723 . . . . 0.0 110.967 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -109.53 8.54 25.18 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.409 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -127.11 109.18 21.65 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 121.859 -0.525 . . . . 0.0 109.637 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -40.17 -38.86 2.31 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 C-N-CA 125.104 3.869 . . . . 0.0 115.42 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.38 -37.84 78.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.089 0.471 . . . . 0.0 111.203 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.93 -23.22 16.43 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.489 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 p -70.92 -28.38 64.46 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.348 0.594 . . . . 0.0 109.888 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.53 -14.57 34.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.826 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.4 ttt -73.33 -46.96 46.34 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 t -119.81 90.49 43.68 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.42 3.55 3.02 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 112.677 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.4 mt -70.3 -31.74 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.478 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 t -132.9 88.17 2.48 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.959 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 116.394 -0.366 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.882 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.5 p -87.46 -74.54 0.44 Allowed 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.8 t 64.07 -46.38 0.28 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.508 1.523 . . . . 0.0 114.085 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 t -94.83 29.49 2.35 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.367 0.667 . . . . 0.0 110.5 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -117.9 128.46 25.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -37.24 -47.7 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 124.809 3.672 . . . . 0.0 115.533 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.82 -39.35 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 11' ' ' MET . 85.8 m -69.37 -38.91 78.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.304 0.574 . . . . 0.0 110.222 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -67.56 -19.54 65.29 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.911 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.49 -40.31 13.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.802 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 22.4 ptp -70.39 -28.46 65.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.333 0.587 . . . . 0.0 110.546 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -136.16 89.11 20.45 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.766 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.98 1.93 8.43 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.975 1.783 . . . . 0.0 110.762 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.34 -12.05 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.532 1.158 . . . . 0.0 108.643 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.9 t -108.86 -70.78 0.79 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.966 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.644 0 O-C-N 122.295 -0.253 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.3 m -70.99 -30.01 66.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.5 m -72.76 -2.49 20.62 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.682 0.754 . . . . 0.0 112.154 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 p -133.57 31.29 3.72 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.626 175.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 2' ' ' CYS . 83.2 t60 -131.52 122.78 19.04 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.038 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -35.52 -60.74 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.047 1 C-N-CA 125.329 4.019 . . . . 0.0 116.078 -174.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' A' ' 11' ' ' MET . 13.8 p -69.12 -35.59 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 35.0 m -73.08 -41.49 64.03 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.223 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 22.7 m -69.88 -8.83 51.83 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.44 -39.58 11.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.4 mmt -64.34 -39.35 93.71 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.006 0.908 . . . . 0.0 109.626 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t -130.22 92.87 34.72 Favored Pre-proline 0 C--N 1.274 -2.682 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.157 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' SER . 57.3 Cg_endo -76.7 3.82 6.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.203 1.936 . . . . 0.0 111.559 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mt -85.22 -15.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.453 1.12 . . . . 0.0 108.819 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 t -145.94 87.56 1.77 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.429 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 116.544 -0.298 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.273 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.4 p -83.93 -70.01 0.6 Allowed 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.038 0.447 . . . . 0.0 110.978 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.1 t 63.1 -69.17 0.07 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 126.344 1.858 . . . . 0.0 113.741 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -90.8 15.6 10.92 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.665 0.745 . . . . 0.0 110.492 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -88.04 132.47 39.76 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.63 -59.53 1.1 Allowed 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 123.157 2.571 . . . . 0.0 111.807 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 75.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t 176.66 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.69 -1.595 . . . . 0.0 107.886 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -63.33 -33.66 76.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.751 0.786 . . . . 0.0 109.478 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.92 -24.11 52.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.347 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.6 mmt -84.88 -35.1 22.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.486 0.66 . . . . 0.0 110.393 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -137.7 90.1 14.81 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.88 3.4 7.0 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.133 1.888 . . . . 0.0 110.185 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.1 mt -75.52 -19.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.012 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t -91.12 90.61 7.89 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.632 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.141 0 O-C-N 122.149 -0.344 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.644 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.5 t -66.12 -33.49 75.91 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.385 0.612 . . . . 0.0 109.642 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.2 m -71.73 -11.07 60.64 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.344 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.6 m -94.91 14.68 20.84 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.905 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' CD2' ' HD2' ' A' ' 6' ' ' PRO . 10.9 t-80 -141.26 132.94 13.7 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 5' ' ' HIS . 1.3 Cg_exo -30.37 -46.88 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.027 1 C-N-CA 125.688 4.258 . . . . 0.0 116.032 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -51.54 -41.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.0 m -104.36 -24.96 13.02 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.759 -0.588 . . . . 0.0 111.068 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -65.85 -35.19 79.98 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.192 0.52 . . . . 0.0 111.548 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 -9.61 47.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.505 0.669 . . . . 0.0 110.137 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -83.09 -48.48 10.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.172 0.987 . . . . 0.0 108.534 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 t -135.48 94.89 14.9 Favored Pre-proline 0 N--CA 1.403 -2.808 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.067 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.47 4.47 5.47 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.377 2.051 . . . . 0.0 110.604 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.4 mt -84.3 -23.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.357 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.9 t -88.07 95.89 10.31 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.535 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.084 0 CA-C-N 116.25 -0.432 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.0 t -89.12 -49.22 6.88 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.402 ' HB3' ' N ' ' A' ' 16' ' ' NH2 . 79.0 m -68.0 -10.1 50.93 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.681 0.792 . . . . 0.0 113.066 -174.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 p -88.61 -1.09 57.88 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.363 0.601 . . . . 0.0 109.948 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -120.8 127.3 26.31 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.393 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -23.61 -57.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 1 C-N-CA 127.01 5.14 . . . . 0.0 117.077 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.62 -41.94 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -83.61 -27.74 28.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -64.06 -36.88 85.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.205 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.74 50.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 tpt -61.68 -42.92 99.59 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.721 0.772 . . . . 0.0 110.869 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -133.01 95.86 18.37 Favored Pre-proline 0 C--N 1.271 -2.816 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.933 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -76.45 -6.07 16.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.949 1.766 . . . . 0.0 110.744 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.4 mt -81.36 -30.78 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 122.789 1.281 . . . . 0.0 107.991 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t -90.49 -58.15 2.59 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 112.596 -2.093 . . . . 0.0 109.223 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . 0.402 ' N ' ' HB3' ' A' ' 3' ' ' CYS . . . . . . . . 0 C--N 1.321 -0.652 0 O-C-N 122.354 -0.216 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.728 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.1 p -78.86 -65.22 1.02 Allowed 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 117.269 0.535 . . . . 0.0 109.57 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.6 t 63.95 -60.87 0.18 Allowed 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 126.165 1.786 . . . . 0.0 115.029 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -94.44 4.03 54.38 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.821 -0.549 . . . . 0.0 111.104 -174.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -89.87 113.17 55.98 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -33.85 -65.37 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.341 1 C-N-CA 125.54 4.16 . . . . 0.0 116.362 -171.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.13 -40.74 88.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.8 t -74.03 -23.32 59.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.977 0.418 . . . . 0.0 110.572 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -72.78 -17.06 61.62 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 121.855 0.836 . . . . 0.0 108.979 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.3 -22.29 18.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mmt -73.3 -33.39 65.17 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.822 0.82 . . . . 0.0 109.186 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.9 t -131.77 92.46 30.51 Favored Pre-proline 0 N--CA 1.412 -2.366 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.205 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.13 4.43 6.21 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.396 2.064 . . . . 0.0 110.264 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.4 -28.32 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.029 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -126.11 -57.26 1.42 Allowed 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.047 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 O-C-N 122.222 -0.299 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.0 t -86.11 -33.09 21.01 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 120.961 0.41 . . . . 0.0 110.27 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 70.8 m -64.83 -15.13 61.4 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.438 0.637 . . . . 0.0 111.843 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t -97.53 3.8 50.55 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -122.24 137.64 27.86 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.28 -43.78 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.406 1 C-N-CA 125.462 4.108 . . . . 0.0 115.317 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.428 ' O ' ' HG3' ' A' ' 11' ' ' MET . 80.9 t -50.74 -65.72 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.748 0.655 . . . . 0.0 111.715 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 78.8 m -82.65 -23.76 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -64.37 -34.71 78.8 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.87 -23.68 31.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.701 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 7' ' ' VAL . 66.6 mtt -70.22 -51.51 30.31 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.046 0.927 . . . . 0.0 109.084 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -123.11 104.47 35.27 Favored Pre-proline 0 N--CA 1.406 -2.66 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.033 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -78.78 -11.76 15.19 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.187 1.925 . . . . 0.0 109.371 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.43 -30.76 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.898 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 34.8 t -94.1 89.31 5.96 Favored 'General case' 0 C--N 1.27 -2.85 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.746 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.237 0 CA-C-N 116.528 -0.305 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.492 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.37 -38.58 91.54 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.1 m -77.45 -6.53 53.79 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.554 0.692 . . . . 0.0 111.243 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.1 p -121.99 15.92 10.82 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.134 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -135.32 113.52 11.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_exo -29.62 -61.64 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.028 1 C-N-CA 126.26 4.64 . . . . 0.0 116.607 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.14 -34.46 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -90.1 -20.85 22.66 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.368 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 m -72.15 -25.03 61.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.78 -39.76 26.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.882 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -61.6 -44.11 97.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.004 0.906 . . . . 0.0 110.294 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -120.79 89.01 44.82 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.619 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.34 3.78 7.51 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.905 1.737 . . . . 0.0 108.807 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.49 -31.25 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 113.881 -1.508 . . . . 0.0 107.497 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t -102.06 -70.28 0.76 Allowed 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.865 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 O-C-N 122.189 -0.319 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.422 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.5 m -68.33 -31.99 71.79 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.4 t -74.69 -7.97 54.92 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.697 0.761 . . . . 0.0 110.14 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t -118.14 8.27 12.35 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.787 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -123.8 106.09 32.07 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -37.82 -52.25 1.72 Allowed 'Trans proline' 0 N--CA 1.488 1.164 1 C-N-CA 125.503 4.136 . . . . 0.0 116.098 -173.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.25 -39.64 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.9 t -84.83 -19.75 31.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.45 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -66.23 -13.55 60.52 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.027 0.441 . . . . 0.0 110.886 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.02 -20.43 55.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.379 . . . . 0.0 109.981 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.5 mmt -76.2 -35.03 59.28 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.68 0.753 . . . . 0.0 109.353 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -127.18 86.38 58.91 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.5 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -74.36 -4.63 15.71 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.675 1.583 . . . . 0.0 110.04 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.88 -14.47 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.113 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.0 t -105.77 -77.86 0.58 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.736 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.18 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.2 m -82.3 -38.95 23.59 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.8 m -67.84 -15.85 63.82 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.951 0.881 . . . . 0.0 110.224 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.8 p -109.46 20.2 18.47 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.825 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -127.8 127.51 23.96 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.0 -45.95 23.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.782 2.988 . . . . 0.0 113.961 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.28 -49.01 79.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.551 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 36.7 m -72.33 -33.52 67.39 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.142 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -70.58 -15.46 62.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 120.96 0.409 . . . . 0.0 110.793 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.43 -34.95 18.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.6 mmm -72.19 -35.51 68.97 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.746 0.784 . . . . 0.0 109.911 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -127.53 87.48 56.02 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.959 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.97 11.06 3.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.548 2.165 . . . . 0.0 110.365 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.97 -19.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.662 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t -128.78 90.82 3.11 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.859 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.961 0 O-C-N 122.157 -0.339 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.932 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.8 t -68.58 -41.8 79.17 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.14 -3.42 29.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.332 0.587 . . . . 0.0 112.125 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m -95.69 4.81 52.67 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.817 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t -90.31 85.24 6.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.442 -0.826 0 CA-C-O 121.553 0.692 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -131.94 125.02 19.99 Favored Pre-proline 0 N--CA 1.435 -1.206 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -25.25 -53.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 1 C-N-CA 126.601 4.867 . . . . 0.0 117.39 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 11' ' ' MET . 27.7 m -65.05 -42.64 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 m -76.81 -31.23 56.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -64.63 -26.03 68.22 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.037 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.71 -15.3 35.16 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.121 0.486 . . . . 0.0 110.595 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.6 mmt -74.32 -51.59 14.72 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -130.38 100.96 17.84 Favored Pre-proline 0 C--N 1.278 -2.535 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.985 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -3.16 12.9 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.197 1.931 . . . . 0.0 111.237 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -92.98 -10.1 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 122.697 1.237 . . . . 0.0 108.581 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.286 -2.166 0 CA-C-N 113.983 -1.462 . . . . 0.0 108.557 179.513 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.802 0.811 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t . . . . . 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 121.259 0.552 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -131.57 126.53 21.13 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -28.81 -54.1 0.15 Allowed 'Trans proline' 0 C--N 1.368 1.569 1 C-N-CA 126.133 4.555 . . . . 0.0 116.086 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.76 -36.0 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.81 -22.72 20.87 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -69.24 -29.2 67.07 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.271 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.99 -28.88 25.48 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.032 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.0 ttt -60.09 -54.13 49.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.137 0.97 . . . . 0.0 109.134 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -133.55 97.41 15.93 Favored Pre-proline 0 C--N 1.272 -2.796 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.882 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.06 3.44 6.15 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.762 2.308 . . . . 0.0 112.387 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.9 mm -97.78 -10.41 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.524 1.154 . . . . 0.0 108.041 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t . . . . . 0 C--N 1.29 -1.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.848 -177.703 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.233 0.54 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -125.82 110.03 25.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -40.85 -50.4 4.05 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 125.009 3.806 . . . . 0.0 115.449 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.5 t -66.59 -31.61 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.811 0.815 . . . . 0.0 110.353 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.1 t -87.77 -17.15 32.28 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.987 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 m -67.74 -16.98 64.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.694 0.759 . . . . 0.0 110.291 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.99 -22.52 20.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.27 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.4 mmm -77.36 -39.42 47.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -125.51 87.58 55.52 Favored Pre-proline 0 C--N 1.273 -2.717 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.83 4.33 3.21 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.4 -32.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.348 1.07 . . . . 0.0 108.189 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.279 -2.494 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.998 176.707 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -138.2 129.63 15.8 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -28.16 -48.33 0.11 Allowed 'Trans proline' 0 C--N 1.369 1.635 1 C-N-CA 126.553 4.835 . . . . 0.0 116.162 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.525 HG23 ' SG ' ' A' ' 8' ' ' CYS . 31.4 m -55.62 -32.24 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 7' ' ' VAL . 4.6 m -107.72 -21.99 12.66 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.559 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -63.53 -39.27 93.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 110.426 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.6 -20.64 33.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.87 -47.75 76.72 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.982 0.896 . . . . 0.0 109.438 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.4 t -135.48 97.43 13.02 Favored Pre-proline 0 C--N 1.277 -2.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.543 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.85 -1.75 11.25 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.268 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.25 -28.66 6.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 123.032 1.396 . . . . 0.0 107.711 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 C--N 1.273 -2.738 0 CA-C-N 112.451 -2.159 . . . . 0.0 109.643 -177.152 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.226 -0.182 0 CA-C-O 121.484 0.659 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -101.98 120.47 53.78 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -37.43 -55.99 0.92 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.636 3.557 . . . . 0.0 115.983 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 11' ' ' MET . 33.2 m -67.54 -28.99 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.472 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.05 -24.25 47.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -18.22 62.93 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.957 0.884 . . . . 0.0 109.579 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.72 -32.3 14.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 25.8 mmt -63.62 -45.39 90.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.737 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -122.27 88.57 48.75 Favored Pre-proline 0 N--CA 1.407 -2.587 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.352 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -84.84 10.5 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.082 1.854 . . . . 0.0 109.431 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 mm -93.71 -19.87 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t . . . . . 0 C--N 1.284 -2.248 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.406 179.467 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.239 0.534 0 CA-C-O 121.393 0.616 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -117.24 108.41 43.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -39.26 -55.39 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 125.254 3.969 . . . . 0.0 115.474 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -24.11 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.467 0.651 . . . . 0.0 111.176 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.26 -11.56 27.72 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.457 0.646 . . . . 0.0 110.094 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -64.2 -11.64 32.87 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.423 0.63 . . . . 0.0 110.231 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.52 -16.53 42.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.219 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.7 tpt -80.65 -35.24 34.11 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.027 0.917 . . . . 0.0 108.735 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -131.4 89.28 41.3 Favored Pre-proline 0 C--N 1.285 -2.218 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.572 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.05 3.83 7.51 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.283 1.989 . . . . 0.0 111.143 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.1 mm -106.32 1.28 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 122.463 1.125 . . . . 0.0 109.091 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.302 -1.461 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.351 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -131.25 110.81 15.31 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.35 -44.52 4.2 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 C-N-CA 124.928 3.752 . . . . 0.0 114.366 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.72 -40.32 84.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.012 0.435 . . . . 0.0 111.4 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.0 m -87.07 -37.33 17.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -65.18 -20.54 66.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.092 0.557 . . . . 0.0 112.368 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.5 -36.44 29.26 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -65.55 -43.3 90.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.177 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -139.89 105.54 6.83 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.461 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.72 -10.97 25.65 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.516 2.144 . . . . 0.0 111.484 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.9 mt -67.99 -29.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 122.541 1.163 . . . . 0.0 109.085 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.271 -2.817 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.805 179.118 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.442 -0.848 0 CA-C-O 120.778 0.323 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -127.11 109.18 21.65 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 121.859 -0.525 . . . . 0.0 109.637 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -40.17 -38.86 2.31 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 C-N-CA 125.104 3.869 . . . . 0.0 115.42 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.38 -37.84 78.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.089 0.471 . . . . 0.0 111.203 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.93 -23.22 16.43 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.489 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 p -70.92 -28.38 64.46 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.348 0.594 . . . . 0.0 109.888 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.53 -14.57 34.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.826 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.4 ttt -73.33 -46.96 46.34 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 t -119.81 90.49 43.68 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.42 3.55 3.02 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 112.677 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.4 mt -70.3 -31.74 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.478 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 t . . . . . 0 C--N 1.279 -2.494 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.959 -179.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.444 -0.733 0 CA-C-O 121.473 0.654 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -117.9 128.46 25.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -37.24 -47.7 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 124.809 3.672 . . . . 0.0 115.533 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.82 -39.35 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 11' ' ' MET . 85.8 m -69.37 -38.91 78.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.304 0.574 . . . . 0.0 110.222 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -67.56 -19.54 65.29 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.911 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.49 -40.31 13.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.802 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 22.4 ptp -70.39 -28.46 65.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.333 0.587 . . . . 0.0 110.546 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -136.16 89.11 20.45 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.766 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.98 1.93 8.43 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.975 1.783 . . . . 0.0 110.762 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.34 -12.05 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.532 1.158 . . . . 0.0 108.643 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.9 t . . . . . 0 C--N 1.294 -1.807 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.966 177.184 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -131.52 122.78 19.04 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.038 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -35.52 -60.74 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.047 1 C-N-CA 125.329 4.019 . . . . 0.0 116.078 -174.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' A' ' 11' ' ' MET . 13.8 p -69.12 -35.59 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.0 m -73.08 -41.49 64.03 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.223 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 22.7 m -69.88 -8.83 51.83 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.44 -39.58 11.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.4 mmt -64.34 -39.35 93.71 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.006 0.908 . . . . 0.0 109.626 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t -130.22 92.87 34.72 Favored Pre-proline 0 C--N 1.274 -2.682 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.157 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' SER . 57.3 Cg_endo -76.7 3.82 6.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.203 1.936 . . . . 0.0 111.559 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mt -85.22 -15.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.453 1.12 . . . . 0.0 108.819 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 C--N 1.289 -2.064 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.429 -179.098 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 121.665 0.745 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -88.04 132.47 39.76 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.63 -59.53 1.1 Allowed 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 123.157 2.571 . . . . 0.0 111.807 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 75.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t 176.66 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.69 -1.595 . . . . 0.0 107.886 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -63.33 -33.66 76.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.751 0.786 . . . . 0.0 109.478 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.92 -24.11 52.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.347 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.6 mmt -84.88 -35.1 22.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.486 0.66 . . . . 0.0 110.393 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -137.7 90.1 14.81 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.88 3.4 7.0 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.133 1.888 . . . . 0.0 110.185 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.1 mt -75.52 -19.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.012 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.285 -2.2 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.632 -178.544 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' CD2' ' HD2' ' A' ' 6' ' ' PRO . 10.9 t-80 -141.26 132.94 13.7 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 5' ' ' HIS . 1.3 Cg_exo -30.37 -46.88 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.027 1 C-N-CA 125.688 4.258 . . . . 0.0 116.032 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -51.54 -41.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.0 m -104.36 -24.96 13.02 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.759 -0.588 . . . . 0.0 111.068 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -65.85 -35.19 79.98 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.192 0.52 . . . . 0.0 111.548 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 -9.61 47.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.505 0.669 . . . . 0.0 110.137 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -83.09 -48.48 10.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.172 0.987 . . . . 0.0 108.534 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 t -135.48 94.89 14.9 Favored Pre-proline 0 N--CA 1.403 -2.808 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.067 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.47 4.47 5.47 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.377 2.051 . . . . 0.0 110.604 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.4 mt -84.3 -23.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.357 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.9 t . . . . . 0 C--N 1.281 -2.405 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.535 -175.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 121.363 0.601 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -120.8 127.3 26.31 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.393 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -23.61 -57.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 1 C-N-CA 127.01 5.14 . . . . 0.0 117.077 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.62 -41.94 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -83.61 -27.74 28.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -64.06 -36.88 85.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.205 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.74 50.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 tpt -61.68 -42.92 99.59 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.721 0.772 . . . . 0.0 110.869 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -133.01 95.86 18.37 Favored Pre-proline 0 C--N 1.271 -2.816 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.933 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -76.45 -6.07 16.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.949 1.766 . . . . 0.0 110.744 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.4 mt -81.36 -30.78 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 122.789 1.281 . . . . 0.0 107.991 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t . . . . . 0 C--N 1.27 -2.868 0 CA-C-N 112.596 -2.093 . . . . 0.0 109.223 -177.13 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 120.964 0.411 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -89.87 113.17 55.98 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -33.85 -65.37 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.341 1 C-N-CA 125.54 4.16 . . . . 0.0 116.362 -171.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.13 -40.74 88.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.8 t -74.03 -23.32 59.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.977 0.418 . . . . 0.0 110.572 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -72.78 -17.06 61.62 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 121.855 0.836 . . . . 0.0 108.979 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.3 -22.29 18.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mmt -73.3 -33.39 65.17 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.822 0.82 . . . . 0.0 109.186 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.9 t -131.77 92.46 30.51 Favored Pre-proline 0 N--CA 1.412 -2.366 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.205 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.13 4.43 6.21 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.396 2.064 . . . . 0.0 110.264 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.4 -28.32 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.029 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.279 -2.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.047 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -122.24 137.64 27.86 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.28 -43.78 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.406 1 C-N-CA 125.462 4.108 . . . . 0.0 115.317 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.428 ' O ' ' HG3' ' A' ' 11' ' ' MET . 80.9 t -50.74 -65.72 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.748 0.655 . . . . 0.0 111.715 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 78.8 m -82.65 -23.76 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -64.37 -34.71 78.8 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.87 -23.68 31.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.701 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 7' ' ' VAL . 66.6 mtt -70.22 -51.51 30.31 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.046 0.927 . . . . 0.0 109.084 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -123.11 104.47 35.27 Favored Pre-proline 0 N--CA 1.406 -2.66 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.033 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -78.78 -11.76 15.19 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.187 1.925 . . . . 0.0 109.371 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.43 -30.76 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.898 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.8 t . . . . . 0 C--N 1.27 -2.85 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.746 -178.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.1 p . . . . . 0 N--CA 1.434 -1.236 0 CA-C-O 120.454 0.169 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -135.32 113.52 11.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_exo -29.62 -61.64 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.028 1 C-N-CA 126.26 4.64 . . . . 0.0 116.607 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.14 -34.46 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -90.1 -20.85 22.66 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.368 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 m -72.15 -25.03 61.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.78 -39.76 26.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.882 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -61.6 -44.11 97.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.004 0.906 . . . . 0.0 110.294 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -120.79 89.01 44.82 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.619 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.34 3.78 7.51 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.905 1.737 . . . . 0.0 108.807 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.49 -31.25 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 113.881 -1.508 . . . . 0.0 107.497 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--N 1.278 -2.538 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.865 177.099 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.548 0.895 0 CA-C-O 121.529 0.681 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -123.8 106.09 32.07 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -37.82 -52.25 1.72 Allowed 'Trans proline' 0 N--CA 1.488 1.164 1 C-N-CA 125.503 4.136 . . . . 0.0 116.098 -173.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.25 -39.64 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.9 t -84.83 -19.75 31.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.45 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -66.23 -13.55 60.52 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.027 0.441 . . . . 0.0 110.886 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.02 -20.43 55.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.379 . . . . 0.0 109.981 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.5 mmt -76.2 -35.03 59.28 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.68 0.753 . . . . 0.0 109.353 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -127.18 86.38 58.91 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.5 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -74.36 -4.63 15.71 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.675 1.583 . . . . 0.0 110.04 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.88 -14.47 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.113 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.287 -2.141 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.604 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.429 -1.497 0 CA-C-O 121.219 0.533 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -127.8 127.51 23.96 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.0 -45.95 23.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.782 2.988 . . . . 0.0 113.961 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.28 -49.01 79.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.551 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.7 m -72.33 -33.52 67.39 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.142 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -70.58 -15.46 62.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 120.96 0.409 . . . . 0.0 110.793 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.43 -34.95 18.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.6 mmm -72.19 -35.51 68.97 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.746 0.784 . . . . 0.0 109.911 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -127.53 87.48 56.02 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.959 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.97 11.06 3.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.548 2.165 . . . . 0.0 110.365 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.97 -19.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.662 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--N 1.288 -2.078 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.859 -177.848 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.802 0.811 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t . . . . . 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.069 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 3.8 t -67.98 -40.75 83.08 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.1 m -66.32 -0.39 2.59 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.975 0.91 . . . . 0.0 113.018 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -97.55 5.9 48.86 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.155 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -131.94 125.02 19.99 Favored Pre-proline 0 N--CA 1.435 -1.206 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -25.25 -53.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 1 C-N-CA 126.601 4.867 . . . . 0.0 117.39 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 11' ' ' MET . 27.7 m -65.05 -42.64 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 4.2 m -76.81 -31.23 56.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -64.63 -26.03 68.22 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.037 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.71 -15.3 35.16 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.121 0.486 . . . . 0.0 110.595 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.6 mmt -74.32 -51.59 14.72 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -130.38 100.96 17.84 Favored Pre-proline 0 C--N 1.278 -2.535 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.985 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -3.16 12.9 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.197 1.931 . . . . 0.0 111.237 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -92.98 -10.1 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 122.697 1.237 . . . . 0.0 108.581 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.0 t -95.4 102.47 14.27 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 113.983 -1.462 . . . . 0.0 108.557 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.03 0 CA-C-N 116.39 -0.368 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.932 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.8 t -68.58 -41.8 79.17 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.14 -3.42 29.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.332 0.587 . . . . 0.0 112.125 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m -95.69 4.81 52.67 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.817 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t -90.31 85.24 6.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.323 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 2.8 t -142.23 -48.39 0.36 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.6 m -56.86 -25.28 56.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.489 0.716 . . . . 0.0 112.773 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.0 m -90.03 18.74 5.51 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.259 0.552 . . . . 0.0 110.936 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -131.57 126.53 21.13 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -28.81 -54.1 0.15 Allowed 'Trans proline' 0 C--N 1.368 1.569 1 C-N-CA 126.133 4.555 . . . . 0.0 116.086 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.76 -36.0 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 3.5 m -90.81 -22.72 20.87 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -69.24 -29.2 67.07 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.271 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.99 -28.88 25.48 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.032 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.0 ttt -60.09 -54.13 49.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.137 0.97 . . . . 0.0 109.134 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -133.55 97.41 15.93 Favored Pre-proline 0 C--N 1.272 -2.796 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.882 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.06 3.44 6.15 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.762 2.308 . . . . 0.0 112.387 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.9 mm -97.78 -10.41 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.524 1.154 . . . . 0.0 108.041 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t -111.69 -60.27 1.87 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.848 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.755 0 CA-C-N 116.352 -0.385 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.072 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.8 p -97.64 -69.01 0.77 Allowed 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.8 t 68.85 -61.51 0.42 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.159 1.384 . . . . 0.0 113.021 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 m -90.37 28.86 1.36 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.233 0.54 . . . . 0.0 112.263 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -125.82 110.03 25.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -40.85 -50.4 4.05 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 125.009 3.806 . . . . 0.0 115.449 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.5 t -66.59 -31.61 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.811 0.815 . . . . 0.0 110.353 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.1 t -87.77 -17.15 32.28 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.987 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 m -67.74 -16.98 64.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.694 0.759 . . . . 0.0 110.291 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.99 -22.52 20.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.27 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.4 mmm -77.36 -39.42 47.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -125.51 87.58 55.52 Favored Pre-proline 0 C--N 1.273 -2.717 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.83 4.33 3.21 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.4 -32.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.348 1.07 . . . . 0.0 108.189 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.1 t -119.95 91.56 3.57 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.998 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.956 0 CA-C-N 116.259 -0.428 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.57 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.421 ' C ' ' HB2' ' A' ' 8' ' ' CYS . 3.0 t -68.01 -49.13 63.38 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 82.7 m -72.15 -1.91 16.73 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.764 0.826 . . . . 0.0 112.835 -175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m -89.05 3.54 51.39 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.169 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -138.2 129.63 15.8 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -28.16 -48.33 0.11 Allowed 'Trans proline' 0 C--N 1.369 1.635 1 C-N-CA 126.553 4.835 . . . . 0.0 116.162 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.525 HG23 ' SG ' ' A' ' 8' ' ' CYS . 31.4 m -55.62 -32.24 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 7' ' ' VAL . 4.6 m -107.72 -21.99 12.66 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.559 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -63.53 -39.27 93.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 110.426 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.6 -20.64 33.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.87 -47.75 76.72 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.982 0.896 . . . . 0.0 109.438 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.4 t -135.48 97.43 13.02 Favored Pre-proline 0 C--N 1.277 -2.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.543 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.85 -1.75 11.25 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.268 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.25 -28.66 6.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 123.032 1.396 . . . . 0.0 107.711 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t -90.79 -58.14 2.58 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 112.451 -2.159 . . . . 0.0 109.643 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.804 0 O-C-N 121.998 -0.439 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.695 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 p -132.32 176.56 8.3 Favored 'General case' 1 N--CA 1.359 -5.009 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 53.2 t -165.35 -53.99 0.03 OUTLIER 'General case' 0 C--N 1.256 -3.493 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.933 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p -88.49 19.68 3.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.484 0.659 . . . . 0.0 111.798 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -101.98 120.47 53.78 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -37.43 -55.99 0.92 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.636 3.557 . . . . 0.0 115.983 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 11' ' ' MET . 33.2 m -67.54 -28.99 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.472 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.05 -24.25 47.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -18.22 62.93 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.957 0.884 . . . . 0.0 109.579 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.72 -32.3 14.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 25.8 mmt -63.62 -45.39 90.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.737 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -122.27 88.57 48.75 Favored Pre-proline 0 N--CA 1.407 -2.587 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.352 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -84.84 10.5 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.082 1.854 . . . . 0.0 109.431 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 mm -93.71 -19.87 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t -107.51 -75.56 0.63 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.406 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.778 0 O-C-N 121.932 -0.48 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.586 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.3 p -114.58 -67.55 0.99 Allowed 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.342 0.591 . . . . 0.0 110.996 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.3 t 66.74 -63.39 0.26 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.535 1.934 . . . . 0.0 113.555 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 m -79.86 19.12 0.71 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.761 0.824 . . . . 0.0 112.457 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -117.24 108.41 43.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -39.26 -55.39 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 125.254 3.969 . . . . 0.0 115.474 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -24.11 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.467 0.651 . . . . 0.0 111.176 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.26 -11.56 27.72 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.457 0.646 . . . . 0.0 110.094 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -64.2 -11.64 32.87 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.423 0.63 . . . . 0.0 110.231 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.52 -16.53 42.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.219 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.7 tpt -80.65 -35.24 34.11 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.027 0.917 . . . . 0.0 108.735 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -131.4 89.28 41.3 Favored Pre-proline 0 C--N 1.285 -2.218 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.572 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.05 3.83 7.51 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.283 1.989 . . . . 0.0 111.143 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.1 mm -106.32 1.28 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 122.463 1.125 . . . . 0.0 109.091 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.6 t -86.3 -85.53 0.16 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.351 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.967 0 O-C-N 121.85 -0.532 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.545 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 1.8 m -64.94 -29.05 69.96 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -177.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.2 m -69.13 -11.75 61.07 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.429 0.633 . . . . 0.0 111.623 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -129.16 29.97 5.08 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.545 ' HB3' ' HA ' ' A' ' 2' ' ' CYS . 12.1 t-80 -131.25 110.81 15.31 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.35 -44.52 4.2 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 C-N-CA 124.928 3.752 . . . . 0.0 114.366 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.72 -40.32 84.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.012 0.435 . . . . 0.0 111.4 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.0 m -87.07 -37.33 17.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -65.18 -20.54 66.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.092 0.557 . . . . 0.0 112.368 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.5 -36.44 29.26 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -65.55 -43.3 90.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.177 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -139.89 105.54 6.83 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.461 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.72 -10.97 25.65 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.516 2.144 . . . . 0.0 111.484 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.9 mt -67.99 -29.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 122.541 1.163 . . . . 0.0 109.085 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.4 t -97.27 90.0 4.95 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.67 -1.605 . . . . 0.0 107.805 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 116.283 -0.417 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.907 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.0 m -65.24 -40.29 93.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.0 -14.57 62.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.619 0.723 . . . . 0.0 110.967 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -109.53 8.54 25.18 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.409 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -127.11 109.18 21.65 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 121.859 -0.525 . . . . 0.0 109.637 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -40.17 -38.86 2.31 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 C-N-CA 125.104 3.869 . . . . 0.0 115.42 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.38 -37.84 78.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.089 0.471 . . . . 0.0 111.203 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.93 -23.22 16.43 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.489 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 p -70.92 -28.38 64.46 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.348 0.594 . . . . 0.0 109.888 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.53 -14.57 34.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.826 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.4 ttt -73.33 -46.96 46.34 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 t -119.81 90.49 43.68 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.42 3.55 3.02 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 112.677 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.4 mt -70.3 -31.74 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.478 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 t -132.9 88.17 2.48 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.959 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 116.394 -0.366 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.882 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.5 p -87.46 -74.54 0.44 Allowed 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.8 t 64.07 -46.38 0.28 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.508 1.523 . . . . 0.0 114.085 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 t -94.83 29.49 2.35 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.367 0.667 . . . . 0.0 110.5 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -117.9 128.46 25.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -37.24 -47.7 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 124.809 3.672 . . . . 0.0 115.533 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.82 -39.35 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 11' ' ' MET . 85.8 m -69.37 -38.91 78.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.304 0.574 . . . . 0.0 110.222 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -67.56 -19.54 65.29 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.911 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.49 -40.31 13.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.802 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 22.4 ptp -70.39 -28.46 65.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.333 0.587 . . . . 0.0 110.546 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -136.16 89.11 20.45 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.766 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.98 1.93 8.43 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.975 1.783 . . . . 0.0 110.762 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.34 -12.05 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.532 1.158 . . . . 0.0 108.643 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.9 t -108.86 -70.78 0.79 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.966 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.644 0 O-C-N 122.295 -0.253 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.3 m -70.99 -30.01 66.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.5 m -72.76 -2.49 20.62 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.682 0.754 . . . . 0.0 112.154 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 p -133.57 31.29 3.72 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.626 175.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 2' ' ' CYS . 83.2 t60 -131.52 122.78 19.04 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.038 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -35.52 -60.74 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.047 1 C-N-CA 125.329 4.019 . . . . 0.0 116.078 -174.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' A' ' 11' ' ' MET . 13.8 p -69.12 -35.59 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 35.0 m -73.08 -41.49 64.03 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.223 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 22.7 m -69.88 -8.83 51.83 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.44 -39.58 11.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 7' ' ' VAL . 26.4 mmt -64.34 -39.35 93.71 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.006 0.908 . . . . 0.0 109.626 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t -130.22 92.87 34.72 Favored Pre-proline 0 C--N 1.274 -2.682 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.157 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' SER . 57.3 Cg_endo -76.7 3.82 6.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.203 1.936 . . . . 0.0 111.559 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mt -85.22 -15.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.453 1.12 . . . . 0.0 108.819 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 t -145.94 87.56 1.77 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.429 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 116.544 -0.298 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.273 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.4 p -83.93 -70.01 0.6 Allowed 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.038 0.447 . . . . 0.0 110.978 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.1 t 63.1 -69.17 0.07 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 126.344 1.858 . . . . 0.0 113.741 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -90.8 15.6 10.92 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.665 0.745 . . . . 0.0 110.492 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -88.04 132.47 39.76 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.63 -59.53 1.1 Allowed 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 123.157 2.571 . . . . 0.0 111.807 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.78 75.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t 176.66 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.69 -1.595 . . . . 0.0 107.886 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -63.33 -33.66 76.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.751 0.786 . . . . 0.0 109.478 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.92 -24.11 52.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.347 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.6 mmt -84.88 -35.1 22.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.486 0.66 . . . . 0.0 110.393 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -137.7 90.1 14.81 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.88 3.4 7.0 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.133 1.888 . . . . 0.0 110.185 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.1 mt -75.52 -19.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.012 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t -91.12 90.61 7.89 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.632 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.141 0 O-C-N 122.149 -0.344 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.644 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.5 t -66.12 -33.49 75.91 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.385 0.612 . . . . 0.0 109.642 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.2 m -71.73 -11.07 60.64 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.344 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.6 m -94.91 14.68 20.84 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.905 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' CD2' ' HD2' ' A' ' 6' ' ' PRO . 10.9 t-80 -141.26 132.94 13.7 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 5' ' ' HIS . 1.3 Cg_exo -30.37 -46.88 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.027 1 C-N-CA 125.688 4.258 . . . . 0.0 116.032 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -51.54 -41.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.0 m -104.36 -24.96 13.02 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.759 -0.588 . . . . 0.0 111.068 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -65.85 -35.19 79.98 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.192 0.52 . . . . 0.0 111.548 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 -9.61 47.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.505 0.669 . . . . 0.0 110.137 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -83.09 -48.48 10.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.172 0.987 . . . . 0.0 108.534 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 t -135.48 94.89 14.9 Favored Pre-proline 0 N--CA 1.403 -2.808 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.067 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.47 4.47 5.47 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.377 2.051 . . . . 0.0 110.604 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.4 mt -84.3 -23.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.357 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.9 t -88.07 95.89 10.31 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.535 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.084 0 CA-C-N 116.25 -0.432 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.0 t -89.12 -49.22 6.88 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.402 ' HB3' ' N ' ' A' ' 16' ' ' NH2 . 79.0 m -68.0 -10.1 50.93 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.681 0.792 . . . . 0.0 113.066 -174.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 p -88.61 -1.09 57.88 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.363 0.601 . . . . 0.0 109.948 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -120.8 127.3 26.31 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.393 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -23.61 -57.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 1 C-N-CA 127.01 5.14 . . . . 0.0 117.077 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.62 -41.94 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -83.61 -27.74 28.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -64.06 -36.88 85.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.205 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.74 50.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 tpt -61.68 -42.92 99.59 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.721 0.772 . . . . 0.0 110.869 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -133.01 95.86 18.37 Favored Pre-proline 0 C--N 1.271 -2.816 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.933 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -76.45 -6.07 16.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.949 1.766 . . . . 0.0 110.744 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.4 mt -81.36 -30.78 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 122.789 1.281 . . . . 0.0 107.991 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t -90.49 -58.15 2.59 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 112.596 -2.093 . . . . 0.0 109.223 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . 0.402 ' N ' ' HB3' ' A' ' 3' ' ' CYS . . . . . . . . 0 C--N 1.321 -0.652 0 O-C-N 122.354 -0.216 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.728 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.1 p -78.86 -65.22 1.02 Allowed 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 117.269 0.535 . . . . 0.0 109.57 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.6 t 63.95 -60.87 0.18 Allowed 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 126.165 1.786 . . . . 0.0 115.029 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -94.44 4.03 54.38 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.821 -0.549 . . . . 0.0 111.104 -174.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -89.87 113.17 55.98 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -33.85 -65.37 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.341 1 C-N-CA 125.54 4.16 . . . . 0.0 116.362 -171.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.13 -40.74 88.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.8 t -74.03 -23.32 59.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.977 0.418 . . . . 0.0 110.572 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -72.78 -17.06 61.62 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 121.855 0.836 . . . . 0.0 108.979 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.3 -22.29 18.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mmt -73.3 -33.39 65.17 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.822 0.82 . . . . 0.0 109.186 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.9 t -131.77 92.46 30.51 Favored Pre-proline 0 N--CA 1.412 -2.366 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.205 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.13 4.43 6.21 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.396 2.064 . . . . 0.0 110.264 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.4 -28.32 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.029 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -126.11 -57.26 1.42 Allowed 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.047 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 O-C-N 122.222 -0.299 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.0 t -86.11 -33.09 21.01 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 120.961 0.41 . . . . 0.0 110.27 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 70.8 m -64.83 -15.13 61.4 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.438 0.637 . . . . 0.0 111.843 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t -97.53 3.8 50.55 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -122.24 137.64 27.86 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.28 -43.78 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.406 1 C-N-CA 125.462 4.108 . . . . 0.0 115.317 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.428 ' O ' ' HG3' ' A' ' 11' ' ' MET . 80.9 t -50.74 -65.72 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.748 0.655 . . . . 0.0 111.715 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 78.8 m -82.65 -23.76 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -64.37 -34.71 78.8 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.87 -23.68 31.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.701 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 7' ' ' VAL . 66.6 mtt -70.22 -51.51 30.31 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.046 0.927 . . . . 0.0 109.084 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -123.11 104.47 35.27 Favored Pre-proline 0 N--CA 1.406 -2.66 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.033 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -78.78 -11.76 15.19 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.187 1.925 . . . . 0.0 109.371 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.43 -30.76 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.898 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 34.8 t -94.1 89.31 5.96 Favored 'General case' 0 C--N 1.27 -2.85 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.746 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.237 0 CA-C-N 116.528 -0.305 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.492 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.37 -38.58 91.54 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.1 m -77.45 -6.53 53.79 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.554 0.692 . . . . 0.0 111.243 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.1 p -121.99 15.92 10.82 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.134 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -135.32 113.52 11.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_exo -29.62 -61.64 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.028 1 C-N-CA 126.26 4.64 . . . . 0.0 116.607 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.14 -34.46 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -90.1 -20.85 22.66 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.368 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 m -72.15 -25.03 61.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.78 -39.76 26.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.882 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -61.6 -44.11 97.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.004 0.906 . . . . 0.0 110.294 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -120.79 89.01 44.82 Favored Pre-proline 0 C--N 1.276 -2.593 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.619 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.34 3.78 7.51 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.905 1.737 . . . . 0.0 108.807 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.49 -31.25 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 113.881 -1.508 . . . . 0.0 107.497 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t -102.06 -70.28 0.76 Allowed 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.865 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 O-C-N 122.189 -0.319 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.422 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.5 m -68.33 -31.99 71.79 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.4 t -74.69 -7.97 54.92 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.697 0.761 . . . . 0.0 110.14 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t -118.14 8.27 12.35 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.787 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -123.8 106.09 32.07 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -37.82 -52.25 1.72 Allowed 'Trans proline' 0 N--CA 1.488 1.164 1 C-N-CA 125.503 4.136 . . . . 0.0 116.098 -173.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.25 -39.64 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.9 t -84.83 -19.75 31.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.45 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -66.23 -13.55 60.52 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.027 0.441 . . . . 0.0 110.886 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.02 -20.43 55.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.379 . . . . 0.0 109.981 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.5 mmt -76.2 -35.03 59.28 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.68 0.753 . . . . 0.0 109.353 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -127.18 86.38 58.91 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.5 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -74.36 -4.63 15.71 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.675 1.583 . . . . 0.0 110.04 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.88 -14.47 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.113 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.0 t -105.77 -77.86 0.58 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.736 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.18 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.2 m -82.3 -38.95 23.59 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.8 m -67.84 -15.85 63.82 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.951 0.881 . . . . 0.0 110.224 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.8 p -109.46 20.2 18.47 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.825 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -127.8 127.51 23.96 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.0 -45.95 23.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.782 2.988 . . . . 0.0 113.961 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.28 -49.01 79.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.551 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 36.7 m -72.33 -33.52 67.39 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.142 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -70.58 -15.46 62.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 120.96 0.409 . . . . 0.0 110.793 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.43 -34.95 18.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.6 mmm -72.19 -35.51 68.97 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.746 0.784 . . . . 0.0 109.911 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -127.53 87.48 56.02 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.959 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.97 11.06 3.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.548 2.165 . . . . 0.0 110.365 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.97 -19.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.662 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t -128.78 90.82 3.11 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.859 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.961 0 O-C-N 122.157 -0.339 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.932 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 1.8 t -68.58 -41.8 79.17 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.14 -3.42 29.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.332 0.587 . . . . 0.0 112.125 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m -95.69 4.81 52.67 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.817 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.16 119.24 22.07 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -33.61 -39.96 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.397 1 C-N-CA 125.978 4.452 . . . . 0.0 116.032 -175.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.02 -53.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 2' ' ' CYS . 2.7 m -85.16 -23.23 28.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -63.34 -35.53 80.69 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 0.0 110.828 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.68 -30.31 29.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.43 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -58.52 -51.39 70.06 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 123.947 0.779 . . . . 0.0 109.558 176.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -128.25 95.87 32.45 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.34 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.49 -8.03 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.986 1.791 . . . . 0.0 110.566 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.5 mt -89.31 -12.59 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 122.869 1.318 . . . . 0.0 108.487 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.5 t -90.31 85.24 6.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_